Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q421670> ?p ?o }
Showing triples 1 to 75 of
75
with 100 triples per page.
- Q421670 subject Q8248726.
- Q421670 subject Q8343668.
- Q421670 subject Q8412954.
- Q421670 subject Q8808791.
- Q421670 abstract "Meropenem is an ultra-broad-spectrum injectable antibiotic used to treat a wide variety of infections. It is a β-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. Meropenem was originally developed by Dainippon Sumitomo Pharma. It gained US FDA approval in July 1996. It penetrates well into many tissues and body fluids, including cerebrospinal fluid, bile, heart valve, lung, and peritoneal fluid. It was initially marketed by AstraZeneca under the trade name Merrem.".
- Q421670 atcPrefix "J01".
- Q421670 atcSuffix "DH02".
- Q421670 bioavailability "100.0".
- Q421670 casNumber "119478-56-7".
- Q421670 chEBI "43968".
- Q421670 drugbank "DB00760".
- Q421670 fdaUniiCode "FV9J3JU8B1".
- Q421670 iupacName "(4R,5S,6S)-3-(((3S,5S)-5-(Dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid".
- Q421670 pubchem "441130".
- Q421670 thumbnail Meropenem.svg?width=300.
- Q421670 wikiPageExternalLink www.merremiv.com.
- Q421670 wikiPageWikiLink Q1087980.
- Q421670 wikiPageWikiLink Q12187.
- Q421670 wikiPageWikiLink Q127076.
- Q421670 wikiPageWikiLink Q186889.
- Q421670 wikiPageWikiLink Q189790.
- Q421670 wikiPageWikiLink Q204711.
- Q421670 wikiPageWikiLink Q215620.
- Q421670 wikiPageWikiLink Q223417.
- Q421670 wikiPageWikiLink Q2509220.
- Q421670 wikiPageWikiLink Q2720606.
- Q421670 wikiPageWikiLink Q292015.
- Q421670 wikiPageWikiLink Q311379.
- Q421670 wikiPageWikiLink Q3775974.
- Q421670 wikiPageWikiLink Q377978.
- Q421670 wikiPageWikiLink Q380136.
- Q421670 wikiPageWikiLink Q40878.
- Q421670 wikiPageWikiLink Q410897.
- Q421670 wikiPageWikiLink Q418201.
- Q421670 wikiPageWikiLink Q41873.
- Q421670 wikiPageWikiLink Q424027.
- Q421670 wikiPageWikiLink Q425152.
- Q421670 wikiPageWikiLink Q54196.
- Q421670 wikiPageWikiLink Q553220.
- Q421670 wikiPageWikiLink Q574905.
- Q421670 wikiPageWikiLink Q632006.
- Q421670 wikiPageWikiLink Q640448.
- Q421670 wikiPageWikiLink Q653197.
- Q421670 wikiPageWikiLink Q65979.
- Q421670 wikiPageWikiLink Q7162855.
- Q421670 wikiPageWikiLink Q7886.
- Q421670 wikiPageWikiLink Q794086.
- Q421670 wikiPageWikiLink Q804539.
- Q421670 wikiPageWikiLink Q8248726.
- Q421670 wikiPageWikiLink Q8343668.
- Q421670 wikiPageWikiLink Q8412954.
- Q421670 wikiPageWikiLink Q857288.
- Q421670 wikiPageWikiLink Q86.
- Q421670 wikiPageWikiLink Q8808791.
- Q421670 wikiPageWikiLink Q909719.
- Q421670 wikiPageWikiLink Q9377.
- Q421670 wikiPageWikiLink Q9629.
- Q421670 atcPrefix "J01".
- Q421670 atcSuffix "DH02".
- Q421670 bioavailability "100.0".
- Q421670 casNumber "119478".
- Q421670 chebi "43968".
- Q421670 drugbank "DB00760".
- Q421670 iupacName "-3".
- Q421670 pubchem "441130".
- Q421670 unii "FV9J3JU8B1".
- Q421670 type ChemicalSubstance.
- Q421670 type Drug.
- Q421670 type ChemicalObject.
- Q421670 type Thing.
- Q421670 type Q8386.
- Q421670 comment "Meropenem is an ultra-broad-spectrum injectable antibiotic used to treat a wide variety of infections. It is a β-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. Meropenem was originally developed by Dainippon Sumitomo Pharma. It gained US FDA approval in July 1996. It penetrates well into many tissues and body fluids, including cerebrospinal fluid, bile, heart valve, lung, and peritoneal fluid.".
- Q421670 label "Meropenem".
- Q421670 depiction Meropenem.svg.
- Q421670 homepage www.merremiv.com.